Equimonet · Source-linked explainer

IBM, Cleveland Clinic and RIKEN Reach Quantum‑Centric Supercomputing Milestone in Protein Simulation

A joint team from Cleveland Clinic, Japan’s RIKEN Center for Computational Science and IBM has been named a finalist for the 2026 ACM Gordon Bell Prize after simulating a 12,635‑atom protein using a hybrid quantum‑classical workflow that blends IBM’s Heron quantum processors with the Fugaku and Miyabi‑G supercomputers.

By Equimonet Research Desk · Published 2026-09-09

Evidence frame

Based on the dated IBM Newsroom announcement linked below. Company statements are not independently verified outcomes. General information, no recommendation.

Primary sources

  1. IBM Newsroom — Cleveland Clinic, RIKEN and IBM Team Advance to Finals for 2026 ACM Gordon Bell Prize Issued 2026-09-09T04:00:00.000Z

General market information only. No investment recommendation.